Neutralizing antibodies after infection with dengue 1 virus

被引:83
作者
Guzman, Maria G.
Alvarez, Mayling
Rodriguez-Roche, Rosmari
Bernardo, Lidice
Montes, Tibaire
Vazquez, Susana
Morier, Luis
Alvarez, Angel
Gould, Ernest A.
Kouri, Gustavo
Halstead, Scott B.
机构
[1] Pedro Kouri Trop Med Inst, Autopista Novia Mediodia, Havana, Cuba
[2] Inst Trop Med, Caracas, Venezuela
[3] Ctr Ecol & Hydrol, Oxford, England
[4] Pediat Dengue Vaccine Initiat, Bethesda, MD USA
基金
英国惠康基金;
关键词
D O I
10.3201/eid1302.060539
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Severity of disease is markedly increased when infection with dengue virus type 2 (DENV-2) follows infection with DENV-1 at an interval of 20 years. Studies have shown that heterologous neutralizing antibody titers are inversely correlated with severity of a second infection. If this mechanism controlled disease severity in Cuba, heterotypic antibody titers should have declined over time. To determine whether phenotypic changes in dengue antibodies occur over time, we analyzed serum samples collected 4-8 and 20-22 years after DENV-1 infection. We found a significant increase in mean titer of homologous DENV-1 neutralizing antibodies and a significant decrease in heterologous antibodies to 1 of 2 genotypes of DENV-2 virus (the American genotype). Asian DENV-2 viruses were not neutralized during either interval; however, the American genotype underwent phenotypic changes in heterotypic viral neutralizing antibodies in the predicted direction. This finding may be related to the time-dependent changes in severity of disease found with secondary dengue infection.
引用
收藏
页码:282 / 286
页数:5
相关论文
共 27 条
[1]  
Alvarez M, 1996, Rev Cubana Med Trop, V48, P53
[2]  
DEFRANCISCO NC, 1981, REV CUBA MED TROP, V33, P72
[3]   Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand [J].
Endy, TP ;
Nisalak, A ;
Chunsuttitwat, S ;
Vaughn, DW ;
Green, S ;
Ennis, FA ;
Rothman, AL ;
Libraty, DH .
JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (06) :990-1000
[4]   SEROLOGICAL DIAGNOSIS OF DENGUE BY AN ELISA INHIBITION METHOD (EIM) [J].
FERNANDEZ, RJ ;
VAZQUEZ, S .
MEMORIAS DO INSTITUTO OSWALDO CRUZ, 1990, 85 (03) :347-351
[5]  
Guzman M G, 1999, Int J Infect Dis, V3, P130, DOI 10.1016/S1201-9712(99)90033-4
[6]  
Guzmán María G., 2002, Rev Panam Salud Publica, V11, P223, DOI 10.1590/S1020-49892002000400003
[7]   PARTIAL NUCLEOTIDE AND AMINO-ACID-SEQUENCES OF THE ENVELOPE AND THE ENVELOPE NONSTRUCTURAL PROTEIN-1 GENE JUNCTION OF 4 DENGUE-2 VIRUS-STRAINS ISOLATED DURING THE 1981 CUBAN EPIDEMIC [J].
GUZMAN, MG ;
DEUBEL, V ;
PELEGRINO, JL ;
ROSARIO, D ;
MARRERO, M ;
SARIOL, C ;
KOURI, G .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1995, 52 (03) :241-246
[8]   Epidemiologic studies on dengue in Santiago de Cuba, 1997 [J].
Guzmán, MG ;
Kouri, G ;
Valdes, L ;
Bravo, J ;
Alvarez, M ;
Vazquez, S ;
Delgado, I ;
Halstead, SB .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2000, 152 (09) :793-799
[9]   SEQUENTIAL INFECTION AS RISK FACTOR FOR DENGUE HEMORRHAGIC-FEVER DENGUE SHOCK SYNDROME (DHF/DSS) DURING THE 1981 DENGUE HEMORRHAGIC CUBAN EPIDEMIC [J].
GUZMAN, MG ;
KOURI, G ;
BRAVO, J ;
SOLER, M ;
MARTINEZ, E .
MEMORIAS DO INSTITUTO OSWALDO CRUZ, 1991, 86 (03) :367-367
[10]   DENGUE HEMORRHAGIC-FEVER IN CUBA .1. SEROLOGICAL CONFIRMATION OF CLINICAL-DIAGNOSIS [J].
GUZMAN, MG ;
KOURI, GP ;
BRAVO, J ;
CALUNGA, M ;
SOLER, M ;
VAZQUEZ, S ;
VENEREO, C .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1984, 78 (02) :235-238